SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001193125-13-440258
Filing Date
2013-11-13
Accepted
2013-11-13 16:30:51
Documents
12
Period of Report
2013-09-30

Document Format Files

Seq Description Document Type Size
1 10-Q d605941d10q.htm 10-Q 318693
2 EX-10.1 d605941dex101.htm EX-10.1 12659
3 EX-31.1 d605941dex311.htm EX-31.1 8246
4 EX-31.2 d605941dex312.htm EX-31.2 8231
5 EX-32.1 d605941dex321.htm EX-32.1 4267
6 EX-32.2 d605941dex322.htm EX-32.2 4252
  Complete submission text file 0001193125-13-440258.txt   3422372

Data Files

Seq Description Document Type Size
7 XBRL INSTANCE DOCUMENT cprx-20130930.xml EX-101.INS 431030
8 XBRL TAXONOMY EXTENSION SCHEMA cprx-20130930.xsd EX-101.SCH 48125
9 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE cprx-20130930_cal.xml EX-101.CAL 48972
10 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE cprx-20130930_def.xml EX-101.DEF 118378
11 XBRL TAXONOMY EXTENSION LABEL LINKBASE cprx-20130930_lab.xml EX-101.LAB 325394
12 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE cprx-20130930_pre.xml EX-101.PRE 210747
Mailing Address 355 ALHAMBRA CIRCLE SUITE 1500 CORAL GABLES FL 33134
Business Address 355 ALHAMBRA CIRCLE SUITE 1500 CORAL GABLES FL 33134 (305) 529-2522
CATALYST PHARMACEUTICAL PARTNERS, INC. (Filer) CIK: 0001369568 (see all company filings)

IRS No.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-33057 | Film No.: 131214998
SIC: 2834 Pharmaceutical Preparations